Endoscopic retrograde cholangiopancreatography-related adverse events: general overview

Gastrointest Endosc Clin N Am. 2015 Jan;25(1):97-106. doi: 10.1016/j.giec.2014.09.005.

Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) represents a monumental advance in the management of patients with pancreaticobiliary diseases, but is a complex and technically demanding procedure with the highest inherent risk of adverse events of all routine endoscopic procedures. Overall adverse event rates for ERCP are typically reported as 5-10%. The most commonly reported adverse events include post-ERCP pancreatitis, bleeding, perforation, infection (cholangitis), and cardiopulomary or "sedation related" events. This article evaluates patient-related and procedure-related risk factors for ERCP-related adverse events, and discusses strategies for the prevention, diagnosis and management of these events.

Keywords: Bleeding; Cholangitiis; Complications; ERCP; Pancreatitis; Perforation; Risk factors; Sphincterotomy.

Publication types

  • Review

MeSH terms

  • Bile Ducts
  • Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
  • Duodenum / injuries
  • Esophageal Perforation / etiology
  • Humans
  • Pancreatitis / complications*
  • Pancreatitis / etiology*
  • Postoperative Hemorrhage / etiology*
  • Risk Factors
  • Stomach / injuries